Side effects
Does the Wegovy pill cause thyroid cancer?
The label says it is unknown. Semaglutide caused thyroid C-cell tumors in rodents, and whether that applies to people has not been determined. The pill is not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2, and a lump in the neck, hoarseness, trouble swallowing or shortness of breath should be reported.
The Oolite team, from the FDA labels
Sources checked Oct 27, 2026
Published Nov 9, 2026
Updated Oct 27, 2026 · 2 min read
The short answer
The label says it is unknown. Semaglutide caused thyroid C-cell tumors in rodents, and whether that applies to people has not been determined. The pill is not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2, and a lump in the neck, hoarseness, trouble swallowing or shortness of breath should be reported.
What the label says
The warning comes first, in a box above everything else, and it covers the injection and the tablets alike. The warnings section (§5.1) says where it comes from:
From the labelIn mice and rats, semaglutide caused a dose-dependent and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure at clinically relevant plasma exposures
And what is known about people:
From the labelIt is unknown whether WEGOVY® causes thyroid C-cell tumors, including MTC, in humans, as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.
The label also mentions the reports that exist in people, for a related medicine, and how much they can say:
From the labelCases of MTC in patients treated with liraglutide, another GLP-1 receptor agonist, have been reported in the postmarketing period; the data in these reports are insufficient to establish or exclude a causal relationship between MTC and GLP-1 receptor agonist use in humans.
Who the pill is not for
Two conditions rule it out:
From the labelWEGOVY ® is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2.
MTC is medullary thyroid carcinoma, one of the thyroid C-cell tumors the box is about. MEN 2 is Multiple Endocrine Neoplasia syndrome type 2, which the Medication Guide calls an endocrine system condition. It says the same in plain words:
From the labelDo not use WEGOVY ® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
The signs to report
The label asks prescribers to talk about the risk and to name the signs:
From the labelCounsel patients regarding the potential risk for MTC with the use of WEGOVY® and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness).
The Medication Guide puts them in everyday words:
From the labelTell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Why there is no routine test
A blood test or a scan can look like the safe option. The label explains why it does not ask for one:
From the labelRoutine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with WEGOVY ®. Such monitoring may increase the risk of unnecessary procedures, due to the low-test specificity for serum calcitonin and a high background incidence of thyroid disease.
So the safeguards the label relies on are the history before the first tablet and the signs during treatment. Both are conversations with the prescriber, and a sign that appears is a reason to tell the prescriber.
Oolite's journal keeps a symptom with its date, so a hoarse voice that lasts or a new discomfort when swallowing is written down with the day it started, ready for the report you bring to your prescriber.
Questions people ask
Does the warning apply to the pill or only to the injection?
To both. The injection and the tablets share one prescribing information and one Medication Guide, and the boxed warning on thyroid C-cell tumors sits at the top of it for both forms.
Who should not take the Wegovy pill?
The label rules it out for anyone with a personal or family history of medullary thyroid carcinoma (MTC) and for anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Family history counts, so it is worth asking relatives before the first appointment.
Should I get a calcitonin test or a thyroid ultrasound?
The label says routine monitoring with either is of uncertain value for early detection of MTC, and may lead to unnecessary procedures. If calcitonin is measured and found elevated, it asks for further evaluation. That is a discussion with the prescriber.
I have thyroid nodules. What does the label say?
It says patients with thyroid nodules found on examination or on neck imaging should be further evaluated. It does not say more than that, so the prescriber who knows the nodules decides.
Sources
- Wegovy prescribing information, Novo Nordisk, Boxed Warning, §4 and §5.1, revised 06/2026 · Thyroid C-cell tumors in rodents; unknown whether Wegovy causes them in humans; liraglutide postmarketing MTC cases insufficient to establish or exclude a causal relationship; contraindicated with personal or family history of MTC or MEN 2; symptoms of thyroid tumors; routine calcitonin or ultrasound monitoring of uncertain value; nodules further evaluated.
- Wegovy Medication Guide, Novo Nordisk, revised 06/2026 · Tell your healthcare provider about a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath; do not use with a personal or family history of MTC or with MEN 2.
Sources checked Oct 27, 2026. This page is information, not medical advice: read the medical disclaimer, and talk to your prescriber or pharmacist about your own treatment.
Written by
The Oolite team, from the FDA labels
We make Oolite. Every answer starts from the FDA prescribing information, quoted word for word, and is rewritten when a label changes.
How these pages are madeOolite
The GLP-1 tracker for the pill and the shot.
The 30 minute timer, your shot day, the level chart and the dose reminder, on iPhone, with Apple Watch to log. Free to download, then a 14-day free trial.
